SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-23-070247
Filing Date
2023-03-14
Accepted
2023-03-14 17:15:28
Documents
4
Effectiveness Date
2023-03-14

Document Format Files

Seq Description Document Type Size
1 S-8 d446624ds8.htm S-8 36118
2 EX-5.1 d446624dex51.htm EX-5.1 4824
3 EX-23.1 d446624dex231.htm EX-23.1 1445
4 EX-FILING FEES d446624dexfilingfees.htm EX-FILING FEES 14979
  Complete submission text file 0001193125-23-070247.txt   58541
Mailing Address THREE BALA PLAZA EAST. SUITE 506 BALA CYNWYD PA 19004
Business Address THREE BALA PLAZA EAST. SUITE 506 BALA CYNWYD PA 19004 844-511-9056
Larimar Therapeutics, Inc. (Filer) CIK: 0001374690 (see all company filings)

IRS No.: 203857670 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-270535 | Film No.: 23731993
SIC: 2834 Pharmaceutical Preparations